BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BRTX trades at $0.17 with a market cap of $4.75M and a P/E ratio of -0.11. BRTX moved -7.84% today. Year to date, BRTX is -85.80%; over the trailing twelve months it is -89.15%. Its 52-week range spans $0.16 to $2.55. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes BRTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $0.17 |
| Market Cap | $4.75M |
| P/E Ratio | -0.11 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.55 |
| 52-Week Low | $0.16 |
| Volume | 83.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $359.70K |
| Net Income | $-14.24M |
| Gross Margin | 93.37% |
2 analysts cover BRTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.